Fineline Cube

Follow:
14778 Articles
Shanghai Henlius Biotech's HLX22 Receives NMPA Approval for Phase II HER2-Targeted Study
CompanyDrug

Shanghai Henlius Biotech’s HLX22 Receives NMPA Approval for Phase II HER2-Targeted Study

Jiangsu Recbio Technology Secures Private Placement with Yangtze River Pharmaceutical for Vaccine Development
CompanyDeals

Jiangsu Recbio Technology Secures Private Placement with Yangtze River Pharmaceutical for Vaccine Development

Hangzhou Chance Pharmaceuticals Partners with Yiling Pharmaceutical for Inhalation Powder Development
CompanyDeals

Hangzhou Chance Pharmaceuticals Partners with Yiling Pharmaceutical for Inhalation Powder Development

GRIT Biotechnology and Vitalgen BioPharma Partner on CRISPR-AaCas12bMAX Cell Therapies
CompanyDeals

GRIT Biotechnology and Vitalgen BioPharma Partner on CRISPR-AaCas12bMAX Cell Therapies

YiChang HEC ChangJiang Pharmaceutical and DP Technology Deepen Partnership with AI Focus
CompanyDeals

YiChang HEC ChangJiang Pharmaceutical and DP Technology Deepen Partnership with AI Focus

Mabwell Bioscience Enters Licensing Agreement for Biosimilar Denosumab in Peru
CompanyDeals

Mabwell Bioscience Enters Licensing Agreement for Biosimilar Denosumab in Peru

Analytical BioSciences Sells Global Rights to Pre-Clinical Anti-Tumor Drugs to Gilead
CompanyDeals

Analytical BioSciences Sells Global Rights to Pre-Clinical Anti-Tumor Drugs to Gilead

"CanSino Biologics Partners with Etana for Inhaled Tuberculosis Vaccine Development
CompanyDeals

CanSino Biologics Partners with Etana for Inhaled Tuberculosis Vaccine Development

Zhida Pharma Secures Licensing Deal for Vivesto AB's Apealea in China
CompanyDeals

Zhida Pharma Secures Licensing Deal for Vivesto AB’s Apealea in China

Guangzhou Innogen Pharmaceutical Files for IPO on Hong Kong Stock Exchange
CompanyDeals

Guangzhou Innogen Pharmaceutical Files for IPO on Hong Kong Stock Exchange

Coherus BioSciences Sells Udenyca Franchise to Intas Pharmaceuticals in Asset Purchase Deal
CompanyDeals

Coherus BioSciences Sells Udenyca Franchise to Intas Pharmaceuticals in Asset Purchase Deal

GSK plc Enters Exclusive Option Agreement with Duality Biologics for ADC Candidate DB-1324
CompanyDeals

GSK plc Enters Exclusive Option Agreement with Duality Biologics for ADC Candidate DB-1324